Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for MandA

Animal Pharm M&A table 2017

Featured here are the animal health mergers and acquisitions covered by Animal Pharm during 2017.

M&A Commercial

Dechra makes a small but significant acquisition in New Zealand

Dechra Pharmaceuticals has again returned to Australasia for its latest acquisition. 

New Zealand Companion Animals

Adisseo acquires Nutriad as it builds on global presence

French animal feed additives specialist Adisseo has acquired Belgian firm Nutriad for an undisclosed amount. 

Europe Asia Pacific

MWI increases its presence on the US east coast with purchase

Leading US veterinary products distributor MWI Animal Health has strengthened its position on the country's eastern seaboard with the purchase of the Northeast Veterinary Supply Company (NEVSCO).

North America United States

Merck expands vaccine potential in Latin America

Merck Animal Health has acquired Uruguayan veterinary vaccine specialist Prondil.

South America Uruguay

Dechra heads towards top 10 as pipeline signifies growing food animal influence

This year, Dechra Pharmaceuticals celebrated its 20th birthday. The previous two decades have seen the firm stimulate its turnover – and share price – with a combination of acquisitions and organic growth. Animal Pharm editor Joseph Harvey takes a look at what the coming years hold for the leading UK-based animal health company.


Inside innovation: How to make strides in animal health

Earlier this month, a joint webinar from Animal Pharm and Kisaco Research canvassed the opinions of three key industry experts regarding the state of innovation in animal health. Animal Pharm editor Joseph Harvey spoke to Nesya Goris of ViroVet, Theo Kanellos from Zoetis and George Gunn from Stonehaven Consulting. Below is a transcript of the webinar.

Pharmaceuticals Vaccines

Virbac puts aquaculture acquisition on hold for three years

Virbac has put its pending acquisition of Chilean fish vaccine business Centrovet on ice for the next three years.

Virbac Chile

Vetoquinol backs monoclonal antibody R&D with stake in plant-based business

Vetoquinol has acquired a small stake in Plant Advanced Technologies (PAT), a fellow French firm focused on developing plant-based biotechnology.

Vetoquinol M&A

MSD's Turkish acquisition puts it at the head of a thriving market

MSD Animal Health is to significantly increase its presence in Turkey by acquiring the country's leading manufacturer of veterinary medicines.

Europe Turkey

Cargill offloads Swiss animal nutrition business to investment firm

Cargill has sold its Switzerland-based animal feed business to German investment company Aurelius Equity Opportunities for an undisclosed fee.

Switzerland Feed & Additives

Zoetis makes manufacturing acquisitions in China and Ireland

Zoetis has purchased the remaining 55% ownership stake in its Jilin Zoetis Guoyuan joint venture.

China Ireland